We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Cancer Genetics Inc | NASDAQ:CGIX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.61 | 4.56 | 4.63 | 0 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
SCHEDULE 13G
|
||
Under the Securities Exchange Act of 1934
|
||
(Amendment No. )*
|
Cancer Genetics, Inc.
|
||
(Name of Issuer)
|
Common Stock, $0.0001 par value per share
|
||
(Title of Class of Securities)
|
13739U203
|
||
(CUSIP Number)
|
February 1, 2021
|
||
(Date of Event which Requires Filing of this Statement)
|
[ ] |
Rule 13d-1(b)
|
[x] |
Rule 13d-1(c)
|
[ ] |
Rule 13d-1(d)
|
(a)
|
Name of Issuer
|
|
Cancer Genetics, Inc.
|
||
(b)
|
Address of Issuer’s Principal Executive Offices
|
|
201 Route 17 North, 2nd Floor
Rutherford, NJ 07070
|
(a)
|
Name of Person Filing
|
|
This statement is filed by the following entities and individuals (collectively, referred to as the “Reporting Persons”):
• Lind Global Macro Fund LP, a Delaware limited partnership;
• Lind Global Partners LLC, a Delaware limited liability company; and
• Jeff Easton, an individual and a citizen of the United States of America.
Lind Global Partners LLC, the general partner of Lind Global Macro Fund, LP, may be deemed to have sole voting and dispositive power with respect to the
shares held by Lind Global Macro Fund, LP.
Jeff Easton, the managing member of Lind Global Partners LLC, may be deemed to have sole voting and dispositive power with respect to the
shares held by Lind Global Macro Fund, LP.
|
||
(b)
|
Address of Principal Business Office or, if none, Residence
|
|
The address of the principal business office for each of the Reporting Persons is:
444 Madison Ave, Floor 41
New York, NY 10022
|
||
(c)
|
Citizenship
|
|
See Row 4 of cover page for each Reporting Person.
|
||
(d)
|
Title of Class of Securities
|
|
Common stock, $0.0001 par value per share.
|
||
(e)
|
CUSIP Number
|
|
13739U203
|
Item 3. |
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
|
|
Not applicable.
|
Item 4. |
Ownership
|
(a)
|
Amount Beneficially Owned
|
|
See Row 9 of cover page for each Reporting Person.
|
||
(b)
|
Percent of Class
|
|
See Row 11 of cover page for each Reporting Person.
|
(c)
|
Number of shares as to which such person has:
|
||
(i)
|
sole power to vote or to direct the vote
|
||
See Row 5 of cover page for each Reporting Person. |
|||
(ii)
|
shared power to vote or to direct the vote
|
||
See Row 6 of cover page for each Reporting Person.
|
|||
(iii)
|
sole power to dispose or to direct the disposition of
|
||
See Row 7 of cover page for each Reporting Person. |
|||
(iv)
|
shared power to dispose or to direct the disposition of
|
||
See Row 8 of cover page for each Reporting Person.
|
Item 5. |
Ownership of Five Percent or Less of a Class
|
Item 6. |
Ownership of More than Five Percent on Behalf of Another Person
|
|
Not applicable.
|
Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
|
|
Not applicable.
|
Item 8. |
Identification and Classification of Members of the Group
|
|
Not Applicable.
|
Item 9. |
Notice of Dissolution of Group
|
|
Not Applicable.
|
Item 10. |
Certification
|
Exhibits |
Exhibit
|
99.1 |
Joint Filing Agreement by and among the Reporting Persons.
|
LIND GLOBAL MACRO FUND, LP
|
||
By:
|
|
Lind Global Partners LLC
|
|
its General Partner
|
|
By:
|
/s/ Jeff Easton
|
|
Name:
|
|
Jeff Easton
|
Title:
|
|
Managing Member
|
LIND GLOBAL PARTNERS LLC
|
||
By:
|
|
/s/ Jeff Easton
|
Name:
|
|
Jeff Easton
|
Title:
|
|
Managing Member
|
JEFF EASTON
|
||
By:
|
|
/s/ Jeff Easton
|
Name:
|
|
Jeff Easton
|
1 Year Cancer Genetics Chart |
1 Month Cancer Genetics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions